US 12133884
Methods of substituting pathogenic amino acids using programmable base editor systems
granted A61KA61K31/7088A61K38/465
Quick answer
US patent 12133884 (Methods of substituting pathogenic amino acids using programmable base editor systems) held by Beam Therapeutics Inc. expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Beam Therapeutics Inc.
- Grant date
- Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/7088, A61K38/465, A61K38/50